MacroGenics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
CCCC
C4 Therapeutics, Inc. |
$3.60 | $320.64 M | -1.97 | 145 | $20.76 M |
CGEM
Cullinan Oncology, Inc. |
$12.18 | $1.29 B | -7.16 | 85 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.67 | $1.12 B | -5.11 | 174 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$26.70 | $1.65 B | -11.47 | 108 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.94 | $243.38 M | -1.59 | 133 | $0 |
INZY
Inozyme Pharma, Inc. |
$2.77 | $286.39 M | -3.43 | 59 | $0 |
IPSC
Century Therapeutics, Inc. |
$1.01 | $244.54 M | -1.32 | 152 | $2.24 M |
KZR
Kezar Life Sciences, Inc. |
$6.72 | $49.85 M | -0.49 | 58 | $7.00 M |
MLYS
Mineralys Therapeutics, Inc. |
$12.31 | $652.38 M | -6.03 | 28 | $0 |
MOLN
Molecular Partners AG |
$4.75 | $135.05 M | -2.03 | 167 | $7.04 M |
NGM
NGM Biopharmaceuticals, Inc. |
$1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
NKTX
Nkarta, Inc. |
$2.49 | $465.09 M | -2.81 | 159 | $0 |
PEPG
PepGen Inc. |
$3.79 | $537.15 M | -5.11 | 76 | $0 |
PHVS
Pharvaris N.V. |
$19.17 | $843.31 M | -5.8 | 83 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.51 | $85.40 M | -1.26 | 63 | $0 |
PTGX
Protagonist Therapeutics, Inc. |
$38.60 | $2.04 B | 13.7 | 126 | $60.00 M |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.22 | $1.66 B | -6.02 | 184 | $0 |
TYRA
Tyra Biosciences, Inc. |
$13.90 | $1.04 B | -11.7 | 49 | $0 |
ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.03 | $754.16 M | -3.26 | 124 | $0 |